Seattle Institute for Biomedical and Clinical Research

Seattle Institute for Biomedical and Clinical Research

Seattle Institute for Biomedical and Clinical Research

Overview
Date Founded

1989

Headquarters

1660 S COLUMBIAN WAY 151F SEATTLE WA 98108-1532

Charitable Causes

Biological & Life Science Research
Medical Research

Employees (Worldwide)

144

Company Description

TO IMPROVE THE HEALTH AND WELL-BEING OF VETERANS THROUGH RESEARCH AND EDUCATION CONDUCTED AT THE VA PUGET SOUND HEALTH CARE SYSTEM. SEATTLE INSTITUTE FOR BIOMEDICAL AND CLINICAL RESEARCH (SIBCR) STRIVES TO PROVIDE OUTSTANDING SUPPORT TO VA STAFF IN THEIR RESEARCH, EDUCATION AND TRAINING ENDEAVORS AND TO FOSTER PROGRESS IN BIOMEDICAL, CLINICAL, REHABILITATIVE AND HEALTH CARE SERVICES. SIBCR PROGRAMS BENEFIT THE NATION'S VETERANS AND THE GENERAL PUBLIC.

Website
Executives & Employees

Executive Director

Chief Financial Officer

President/Vice President

Research Manager

Research Nurse

Board of Directors

President/Vice President at Seattle Institute for Biomedical and Clinical Research

Co-Director of the Molecular Medicine & Mechanisms of Disease at University of Washington - School of Medicine

Director at Seattle Institute for Biomedical and Clinical Research

Paths to Seattle Institute for Biomedical and Clinical Research
Potential Connections via
Relationship Science
You
Seattle Institute for Biomedical and Clinical Research
Key Stats and Financials As of 2019
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$15.9M
Non-Profit Donations & Grants Received
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Seattle Institute for Biomedical and Clinical Research. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Seattle Institute for Biomedical and Clinical Research's profile does not indicate a business or promotional relationship of any kind between RelSci and Seattle Institute for Biomedical and Clinical Research.